Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127765161 | 12776516 | 1 | I | 20160914 | 20160923 | 20160923 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076363 | BRISTOL MYERS SQUIBB | 74.00 | YR | M | Y | 0.00000 | 20160923 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127765161 | 12776516 | 1 | PS | ORENCIA | ABATACEPT | 1 | Unknown | U | 125118 | ||||||||||
| 127765161 | 12776516 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | U | 0 | ||||||||||
| 127765161 | 12776516 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | ||||||||||
| 127765161 | 12776516 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 127765161 | 12776516 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 127765161 | 12776516 | 6 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 127765161 | 12776516 | 7 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 127765161 | 12776516 | 8 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127765161 | 12776516 | 1 | Rheumatoid arthritis |
| 127765161 | 12776516 | 2 | Rheumatoid arthritis |
| 127765161 | 12776516 | 3 | Rheumatoid arthritis |
| 127765161 | 12776516 | 4 | Rheumatoid arthritis |
| 127765161 | 12776516 | 5 | Rheumatoid arthritis |
| 127765161 | 12776516 | 6 | Rheumatoid arthritis |
| 127765161 | 12776516 | 7 | Rheumatoid arthritis |
| 127765161 | 12776516 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127765161 | 12776516 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127765161 | 12776516 | Arthropathy | |
| 127765161 | 12776516 | Chest pain | |
| 127765161 | 12776516 | Drug dose omission | |
| 127765161 | 12776516 | Drug ineffective | |
| 127765161 | 12776516 | Dysphonia | |
| 127765161 | 12776516 | Gastrooesophageal reflux disease | |
| 127765161 | 12776516 | Musculoskeletal pain | |
| 127765161 | 12776516 | Musculoskeletal stiffness | |
| 127765161 | 12776516 | Nephrolithiasis | |
| 127765161 | 12776516 | Prostate cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |